In early 2000s there was an epidemic….and then it died down. Have we successfully eliminated the scourge of NSF by appropriately changing our behaviour? Perhaps the pendulum has swung too much and needs to come back to the middle.
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
This week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN.
2025 was rich in successful stories. Here are the top 10 that impressed our audience.